Keywords
Syndrome Metabolic
Obesity
High blood pressure
Dyslipidemia
Periodontal Disease
Periodontal Parameters
How to Cite
Abstract
Background. Periodontal disease (PD) is a chronic inflammatory condition that destroys dental support tissues, leading to tooth loss. It is associated with Metabolic Syndrome (MS), which includes obesity, dyslipidemia, and hypertension. Combined with PD parameters, these factors contribute to an increased risk of cardiovascular problems. Aim. To evaluate the relationship between MS components and PD parameters in patients with type 2 diabetes (T2D). Methods A descriptive and correlational study was conducted. Clinical records of 39 patients with PD and T2D from the Dr. Rafael Lucio High Specialty Center in Xalapa, Veracruz, were analyzed. Results Significant correlations were identified between probing bleeding levels and glucose levels (r=0.3452, p=0.0214), mean arterial pressure and clinical attachment levels (r=0.3322, p=0.0268), and probing bleeding with mean arterial pressure (r=0.5346, p=0.0268). Conclusion: A direct relationship was observed between the components of MS and the clinical parameters of periodontal disease.
References
Albandar, J. M., Susin, C., y Hughes, F. J. (2018). Manifestations of systemic diseases and conditions that affect the periodontal attachment apparatus: Case definitions and diagnostic considerations. Journal of clinical periodontology, 45(Suppl 20), S171–S189. https://doi.org/10.1111/jcpe.12947
Fahed, G., Aoun, L., Bou-Zerdan, M., Allam, S., Bou-Zerdan, M., Bouferraa, Y. y Assi, HI. (2021). Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci, 23(2), 786. https://doi.org/10.3390/ijms23020786
Heikkilä, P., Hlushchenko, T., Batig, M., Borysenko, A., Tokar, O., Batih, I., Vynogradova, O. y Boychuk-Tovsta, O. (2020). Prevalence and intensity of periodontal diseases in individuals with metabolic syndrome. J. Med Life, 13(3), 289-292. https://doi.org/10.25122/jml-2020-0073
Jepsen, S., Suvan, J., Deschner, J. (2020). The association of periodontal diseases with metabolic syndrome and obesity. Periodontol 2000, 83(1), 125-153. https://doi.org/10.1111/prd.12326
Katsimardou, A., Imprilaos, K., Stavropolos, K., Sachinidis, A., Doumas, M. y Athyros, V. (2020). Hypertension in metabolic syndrome: Novel Insights. Curr Hypertens Rev, 16(1), 12-18. http://dx.doi.org/10.2174/1573402115666190415161813
Kawabata, Y., Ekuni, D., Miyai, H., Kataoka, K., Yamane, M., Mizutani, S., Irie, K., Azuma, T., Tomofuji, T., Iwasaki, Y., & Morita, M. (2016). Relationship between prehypertension/hypertension and periodontal disease: A prospective cohort study. American Journal of Hypertension, 29(3), 388–396. https://doi.org/10.1093/ajh/hpv117
Mikami, R., Mizutani, K., Matsuyama, Y., Matsuura, T., Kido, D., Takeda, K., Takemura, S., Nakagawa, K., Mukaiyama, Y., Suda, T., Yasuda, T., Ohta, S., Takaya, N., Fujkiwara, T., Izumi, Y. y Iwata, T. (2021). Association between periodontal inflammations and serum lipid profile in healthy population: A cross-sectional study. J Periodont Res, 56(6), 1-9. https://doi.org/10.1111/jre.12917
Nesse, W., Abbas, F., Van der Ploeg, I., Spijkervet, F., Dijkstra, P., Vissink, A. (2008). Periodontal Inflamed area: quantifying inflammatory burden. J Clin Periodontol, 35(8), 668-673. https://doi.org/10.1111/j.1600-051X.2008.01249.x
Pietropaoli, D., Del pinto, R., Ferri, C., Wright, J. T., Giannoni, M., Ortu, E., Monaco, A. (2018). Poor oral Health and blood pressure control among US Hypertensive Adults. Hypertension AHA, 72(6), 1365-1373. https://doi.org/10.1161/hypertensionaha.118.11528
Preshaw, P., Taylor, J., Jaedicke, K., De Jager, M., Bikker, J, Selten W, Bissett S, Whall K, Van de Merwe R, Areibi A, Jitprasertwong P, Al-Shahwani R., Weaver, J., Taylor, R. y Wassall, R. (2020). Treatment of periodontitis reduces systemic inflammation in type 2 diabetes. J. Clin Periodontiol, 47(6), 737-746. https://doi.org/10.1111/jcpe.13274
Saklayen, M. G. (2018). The Global Epidemic of the Metabolic Syndrome. Curr. Hypertens Rep,20(2):1-8. https://doi.org/10.1007/s11906-018-0812-z
Sherling, D. H., Perumareddi, P. y Hennekens, H. (2017). Metabolic Syndrome: Clinical and Policy Imnplications of the new silent killer. J. Cardiovasc. Pharmacol Ther, 22(4), 365-367. https://doi.org/10.1177/1074248416686187
Srikanth, S., y Deedwania, P. (2016). Management of dyslipidemia in patients with hypertension, diabetes, and metabolic syndrome. Current Hypertension Reports, 18(10), 76. https://doi.org/10.1007/s11906-016-0683-0
Srivastava, M., Srivastava, R., Kumar-Verma, P., Gautam, A. (2019). Metabolic syndrome and periodontal disease: An Overview for physicians. J Family Med Prim Care, 8(11), 3492-3495. https://doi.org/10.4103/jfmpc.jfmpc_866_19
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2025 José Carlos Alarcón-Moreno , María Gabriela Nachón-García, Mónica Flores-Muñoz , Francisco Javier Nachón-García , Miguel Eric García-Rivera , Víctor Hugo Muñoz-Muñoz